Employees Retirement System of Texas Invests $590,000 in HCA Healthcare, Inc. $HCA

Employees Retirement System of Texas purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,540 shares of the company’s stock, valued at approximately $590,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Brighton Jones LLC bought a new position in HCA Healthcare in the 4th quarter valued at $1,021,000. Cetera Investment Advisers raised its holdings in shares of HCA Healthcare by 10.3% in the first quarter. Cetera Investment Advisers now owns 32,168 shares of the company’s stock valued at $11,116,000 after buying an additional 2,997 shares during the last quarter. LPL Financial LLC grew its holdings in HCA Healthcare by 6.3% during the 1st quarter. LPL Financial LLC now owns 65,463 shares of the company’s stock worth $22,621,000 after acquiring an additional 3,882 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in shares of HCA Healthcare by 95.2% in the first quarter. Geneos Wealth Management Inc. now owns 6,458 shares of the company’s stock worth $2,232,000 after acquiring an additional 3,149 shares during the last quarter. Finally, XTX Topco Ltd bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $1,830,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on HCA. Jefferies Financial Group increased their price objective on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday, October 28th. Stephens lifted their price objective on HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Zacks Research upgraded shares of HCA Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 29th. Raymond James Financial set a $525.00 price target on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a report on Thursday, November 13th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $474.53.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

HCA opened at $514.67 on Friday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $520.00. The firm has a market cap of $117.44 billion, a PE ratio of 19.89, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. The firm’s fifty day moving average is $449.85 and its two-hundred day moving average is $405.08.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter last year, the business posted $4.90 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is presently 11.13%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.